| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/04/2004 | EP1385952A2 Methods of inhibiting expression of a target gene in mammalian cells |
| 02/04/2004 | EP1385948A2 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
| 02/04/2004 | EP1385947A1 Compositions and methods to control bleeding |
| 02/04/2004 | EP1385945A1 Novel mutation |
| 02/04/2004 | EP1385942A2 Regulation of target protein activity through modifier proteins |
| 02/04/2004 | EP1385940A2 47169 and 33935, human glycosyl transferases and uses therefor |
| 02/04/2004 | EP1385935A1 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway |
| 02/04/2004 | EP1385887A1 Repressors for hiv transcription and methods thereof |
| 02/04/2004 | EP1385884A2 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. |
| 02/04/2004 | EP1385883A2 Transmembrane proteins |
| 02/04/2004 | EP1385882A2 Peptides and related molecules that bind to tall-1 |
| 02/04/2004 | EP1385881A1 Anti-obesity polypeptides |
| 02/04/2004 | EP1385878A2 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds |
| 02/04/2004 | EP1385877A2 Polypeptides |
| 02/04/2004 | EP1385876A2 Gonococcal proteins and nucleic acids |
| 02/04/2004 | EP1385875A2 Epitopes of virus hepatitis c specifically cd4+ t-lymphocytes |
| 02/04/2004 | EP1385874A1 Alpha conotoxin peptides with analgesic properties |
| 02/04/2004 | EP1385873A2 A ligand for enhancing oral and cns delivery of biological agents |
| 02/04/2004 | EP1385872A1 Inhibitors of receptor activator of nf-kappa b and uses thereof |
| 02/04/2004 | EP1385871A1 Process for inactivating prions in lipoproteins |
| 02/04/2004 | EP1385870A2 Peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 02/04/2004 | EP1385864A1 Vascular endothelial growth factor 2 |
| 02/04/2004 | EP1385863A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/04/2004 | EP1385861A2 Compositions and methods relating to lung specific genes and proteins |
| 02/04/2004 | EP1385555A1 Viral vectors having reduced virulence |
| 02/04/2004 | EP1385553A1 Soluble protein-polymer systems for drug delivery |
| 02/04/2004 | EP1385549A2 Combination of nateglinide or repaglinide with at least one further antidiabetic compound |
| 02/04/2004 | EP1385548A2 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |
| 02/04/2004 | EP1385546A1 Combination therapy using anti-egfr antibodies and anti-hormonal agents |
| 02/04/2004 | EP1385537A1 Medical device |
| 02/04/2004 | EP1385536A2 Preparations containing a combination of vitamin e and afamin |
| 02/04/2004 | EP1385535A2 Modified fvii in treatment of ards |
| 02/04/2004 | EP1385534A2 Ccr5 antagonist and dp-178 polypeptide for treating viral infections |
| 02/04/2004 | EP1385533A1 Module of pd-1 interactions with its ligands |
| 02/04/2004 | EP1385532A1 Stimulation of osteogenesis using rank ligand fusion proteins |
| 02/04/2004 | EP1385524A1 Pyrazolopyrimidines as therapeutic agents |
| 02/04/2004 | EP1385498A2 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 02/04/2004 | EP1385489A1 Coated granules based on angiotensin-converting enzyme inhibitor |
| 02/04/2004 | EP1385476A2 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions |
| 02/04/2004 | EP1385381A2 Human secreted proteins |
| 02/04/2004 | EP1385380A2 Human secreted proteins |
| 02/04/2004 | EP1296947B1 $g(A) CRYSTALLINE FORM OF PERINDOPRIL TERT-BUTYLAMINE SALT |
| 02/04/2004 | EP1189615B1 Endoparasiticidal synergistic combination containing cyclic depsipeptides and piperazines |
| 02/04/2004 | EP1185291B1 Therapeutic agent comprising a botulinum neurotoxin |
| 02/04/2004 | EP1162985B1 Matrix protein compositions for induction of apoptosis |
| 02/04/2004 | EP1030839B1 Use of alkylated iminosugars to treat multidrug resistance |
| 02/04/2004 | EP0973543B1 Method for inactivating pathogens, especially viruses, in a biological material |
| 02/04/2004 | EP0966293B1 Medicine for promoting cicatrization and containing thrombocytes |
| 02/04/2004 | EP0938578B1 Genetic modification of primate hemopoietic repopulating stem cells |
| 02/04/2004 | EP0938333B1 Method of enhancing the delivery of growth factors |
| 02/04/2004 | EP0925067B1 Graft from submucosal intestinal tissue for repairing neurological tissue |
| 02/04/2004 | EP0848755B9 Vegf-related protein |
| 02/04/2004 | EP0777731B1 Cloning and regulation of an endothelial cell protein c/activated protein c receptor |
| 02/04/2004 | EP0698094B1 Bmp-11 compositions |
| 02/04/2004 | EP0670848B1 High molecular weight collagen-like protein polymers |
| 02/04/2004 | EP0642507B1 Transition state analogues of cocaine, their use for producing catalytic antibodies against cocaine and use of the same in diagnosis and therapy |
| 02/04/2004 | CN1473166A Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 02/04/2004 | CN1473061A Antithrombotic compositions |
| 02/04/2004 | CN1473055A Methods for enhancing efficacy of cytotoxic agents through use of HSP90 inhibitors |
| 02/04/2004 | CN1473050A Use of long pentraxin PTX3 for treatment of diseases caused by altered activation of growth factor FGF-2 |
| 02/04/2004 | CN1472332A Target for medicine against Sars-Cov and medicine screening method and medicine against Sars |
| 02/04/2004 | CN1472319A Method of expressing thymys peptide alpha by yeast and use thereof |
| 02/04/2004 | CN1472224A Holothurian extracts with anti-cancer activity and their preparation and use |
| 02/04/2004 | CN1471977A Gene recombined medicine of adenovirus carrier and p53 gene for treating proliferative diseases |
| 02/04/2004 | CN1471972A Fibrin ferment hemostatic suppository |
| 02/04/2004 | CN1471971A Use of recombined human granulocyte colony stimulating factor in preparation of medicine for myocardiac infarction |
| 02/04/2004 | CN1471970A Recombination low-dosage human alpha-2b(IFN-alpha-2b) interferon lozenge and preparing method thereof |
| 02/04/2004 | CN1471969A Medicinal use of recombined human interleukin-1 receptor antagonist |
| 02/04/2004 | CN1471968A Medicinal use of recombined human interleukin-1 receptor antagonist |
| 02/04/2004 | CN1471967A Composition for preventing or treating tumour malignant change or tumour transfer and method thereof |
| 02/04/2004 | CN1137264C Specific DNA sequence of oriental vole and its use |
| 02/04/2004 | CN1137262C Mutants of Rb and P53 genes and uses thereof |
| 02/04/2004 | CN1137138C Fluridated micellar casein |
| 02/04/2004 | CN1137136C Targeted cytotoxic anthracycline analogs |
| 02/04/2004 | CN1137135C Ribosome deactivating protein originating from octagon towel gourd |
| 02/04/2004 | CN1137134C Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors |
| 02/04/2004 | CN1136920C Gene transfer-mediated angiogenesis therapy |
| 02/04/2004 | CN1136916C Long-acting injection suspensions and process for their preparation |
| 02/04/2004 | CN1136915C Use of nona-and decapeptides in the preparation of drug for treatment of aids |
| 02/04/2004 | CN1136914C Method for identifying or isolating molecule and molecules identified therby |
| 02/03/2004 | US6687428 Optical switch |
| 02/03/2004 | US6686455 Tumor necrosis factor |
| 02/03/2004 | US6686450 Immunosuppressive agents that inhibit calcineurin function and uses of these agents |
| 02/03/2004 | US6686447 Use of polynucleotides encoding polypeptides that comprise at least a portion of a lung tumor protein combined with physio-logical acceptable carrier providing immunogenic compositions /vaccine for prophylactic/therapeutic use against lung cancer |
| 02/03/2004 | US6686445 Esterification of 2-hydroxyisovaleric acid and tboc-l-proline; salt formation with trifluoracetic acid; deprotecting and reacting with n,n'-dimethylvaline |
| 02/03/2004 | US6686444 Osteopontin derived chemotactic peptides and methods of use |
| 02/03/2004 | US6686442 Peptide nucleic acid for use in veterinary medicine |
| 02/03/2004 | US6686397 Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity |
| 02/03/2004 | US6686358 Anticoagulants; cardoviscular disorders |
| 02/03/2004 | US6686338 Enzyme inhibitors for metabolic redirection |
| 02/03/2004 | US6686336 N-terminal D(-)-penicillamine peptides as aldehyde sequestration agents |
| 02/03/2004 | US6686335 Hydroxamate-containing cysteine and serine protease inhibitors |
| 02/03/2004 | US6686334 Decrease hyperalgesia, without impairing nociception |
| 02/03/2004 | US6686333 Inhibition of HIV replication using soluble Tat peptide analogs |
| 02/03/2004 | US6686332 Method of treating depressed reticuloendothelial system function |
| 02/03/2004 | US6686198 Preventing or antagonizing signaling pathway in cell for growth factor of tgf-beta family resulting in neuronal differentiation |
| 02/03/2004 | US6686192 Antisense RNA expression strategies effective against Streptococcus thermophilus bacteriophages |
| 02/03/2004 | US6686190 Methods for enhancing the production of viral vaccines in cell culture |
| 02/03/2004 | US6686188 Polynucleotide encoding a human myosin-like polypeptide expressed predominantly in heart and muscle |
| 02/03/2004 | US6686187 Nucleotide sequences coding polypeptide for use in treatment of arteriosclerosis, inflammation and psoriasis |